Castle Biosciences (CSTL) Retained Earnings (2018 - 2026)
Castle Biosciences' Retained Earnings history spans 8 years, with the latest figure at -$224.3 million for Q4 2025.
- On a quarterly basis, Retained Earnings fell 97614.78% to -$224.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$224.3 million, a 97614.78% decrease, with the full-year FY2025 number at -$224.3 million, down 97614.78% from a year prior.
- Retained Earnings hit -$224.3 million in Q4 2025 for Castle Biosciences, down from -$222.0 million in the prior quarter.
- Over the last five years, Retained Earnings for CSTL hit a ceiling of $230000.0 in Q4 2024 and a floor of -$226.0 million in Q1 2025.
- Historically, Retained Earnings has averaged -$90.7 million across 5 years, with a median of -$75.6 million in 2021.
- Biggest five-year swings in Retained Earnings: skyrocketed 100.08% in 2023 and later crashed 295274.65% in 2024.
- Tracing CSTL's Retained Earnings over 5 years: stood at -$87.4 million in 2021, then plummeted by 84.19% to -$160.9 million in 2022, then skyrocketed by 100.08% to $136000.0 in 2023, then surged by 69.12% to $230000.0 in 2024, then crashed by 97614.78% to -$224.3 million in 2025.
- Business Quant data shows Retained Earnings for CSTL at -$224.3 million in Q4 2025, -$222.0 million in Q3 2025, and $39000.0 in Q2 2025.